| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |